![]() It is currently under review by the FDA for approval in the US. The FreeStyle Libre 2 system is currently approved in Europe. ![]() Abbott and Insulet PartnershipĪbbott and Insulet announced a similar partnership: they will combine Abbott’s next-generation FreeStyle Libre 2 CGM sensor with the Omnipod Horizon AID system. Dexcom and Insulet Partnershipĭexcom’s G6 and upcoming G7 will be combined with Insulet’s AID system to predict blood sugar levels and dose insulin, with the aim of keeping users within their target blood sugar range. The dual-partnerships mean that Horizon will be the first AID system with two CGM partners. Insulet announced plans to integrate Abbott’s FreeStyle Libre 2 (still under FDA review) and Dexcom’s G6, and upcoming G7 (launch in 2021), into Insulet’s Omnipod Horizon automated insulin delivery ( AID) system (launch in early 2021).ĪID systems use CGM and smart algorithms to automatically adjust insulin delivery via pump. In a major splash at the 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Madrid, Spain, Insulet unveiled partnerships with continuous glucose monitor ( CGM) companies Abbott and Dexcom. ![]() Insulet partners with Abbott and Dexcom to develop Omnipod Horizon systems By Eliza Skoler, Rhea Teng, and Albert Cai
0 Comments
Leave a Reply. |